European Review for Medical and Pharmacological Sciences

Top Research Topics at European Review for Medical and Pharmacological Sciences?

The journal facilitates discussions on Internal medicine, Cancer research, Cell growth, Apoptosis and Endocrinology. In it, Gastroenterology, Surgery, Oncology and Cardiology are investigated in conjunction with one another to address concerns in Internal medicine research. European Review for Medical and Pharmacological Sciences holds forums on Cancer research that merges themes from other disciplines such as Cell culture, Transfection, Gene knockdown, Downregulation and upregulation and microRNA.

The study on microRNA presented in the journal intersects with the topics under Reporter gene. The research on Cell growth featured in it combines topics in other fields like Cell, Cell cycle, Metastasis, Regulation of gene expression and Western blot. Topics in Apoptosis explored in it were investigated in conjunction with research in Molecular biology, Flow cytometry and Signal transduction.

• Internal medicine (31.34%)
• Cancer research (21.84%)
• Cell growth (12.78%)

What are the most cited papers published in the journal?

• Epidemiology of gastrointestinal and liver tumors. (300 citations)
• Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143. (238 citations)
• Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. (231 citations)

Research areas of the most cited articles at European Review for Medical and Pharmacological Sciences:

The journal publications primarily tackle Internal medicine, Cancer research, Endocrinology, Cell growth and Surgery. The journal articles with studies in Internal medicine featured incorporate elements of Gastroenterology, Diabetes mellitus and Oncology. While the published papers focused on Cancer research, they were also able to explore topics like Cell culture, Apoptosis, Gene knockdown, Downregulation and upregulation and microRNA.

What topics the last edition of the journal is best known for?

• Internal medicine
• Surgery
• Disease

The previous edition focused in particular on these issues:

European Review for Medical and Pharmacological Sciences is mainly concerned with subjects like Internal medicine, Cancer research, Coronavirus disease 2019 (COVID-19), MEDLINE and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The journal explores issues in Internal medicine which can be linked to other research areas like Gastroenterology, Endocrinology and Oncology. Cancer research research featured in the journal incorporates concerns from various other topics such as Cell culture, Apoptosis, Gene knockdown, Cell growth and Downregulation and upregulation.

The journal features studies on Coronavirus disease 2019 (COVID-19), including topics such as Pandemic. Studies on MEDLINE discussed in European Review for Medical and Pharmacological Sciences link to the field of Intensive care medicine. It links adjacent topics like Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with Virology.

The most cited articles from the last journal are:

• COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. (68 citations)
• Early combination treatment with existing HIV antivirals: an effective treatment for COVID-19? (10 citations)
• Hsa_circ_0007534 knockdown represses the development of colorectal cancer cells through regulating miR-613/SLC25A22 axis (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in European Review for Medical and Pharmacological Sciences (based on the number of publications) are:

• Antonio Gasbarrini (80 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• Alessandro Gasbarrini (68 papers) published 8 papers at the last edition, 12 less than at the previous edition,
• Jian Liu (61 papers) published 2 papers at the last edition, 4 less than at the previous edition,
• Francesco Franceschi (60 papers) published 4 papers at the last edition, 14 less than at the previous edition,
• Jian Zhang (54 papers) published 3 papers at the last edition, 5 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in European Review for Medical and Pharmacological Sciences (based on the number of publications) are:

• Sapienza University of Rome (497 papers) published 22 papers at the last edition, 13 less than at the previous edition,
• Catholic University of the Sacred Heart (320 papers) published 19 papers at the last edition, 16 less than at the previous edition,
• Shandong University (181 papers) published 9 papers at the last edition, 17 less than at the previous edition,
• Qingdao University (171 papers) published 3 papers at the last edition, 16 less than at the previous edition,
• Jilin University (123 papers) published 4 papers at the last edition, 37 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 30.97% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 17.30% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.84% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.89% of all publications and 60.97% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Licensing Requirements for Nurses Engaging in Medical and Pharmacological Research

The field of medical and pharmacological research offers a variety of career opportunities for professionals, especially nurses. Nurses play a pivotal role in this sector because of their unique skills in patient care, data collection, and ability to interact with diverse patients. They contribute to significant research areas such as internal medicine, gastroenterology, oncology, cardiology, and apoptosis among others known to this journal. However, it's vital to understand that to venture into these fields, nurses should be properly licensed according to the legislation of the area in which they want to work. For instance, nurses who want to work in Texas should familiarize themselves with the texas nursing license requirements to stay compliant and contribute to making significant strides in the medical and pharmacological field. Moreover, in research, continuous learning and staying updated with innovative trends is a must. Attaining additional certifications or degrees can give a significant advantage to nurses willing to excel in this field. Highly-credentialed nurses can become expert researchers or influential policy-makers, shaping the future of healthcare. This section aims to inspire nurses around the world to consider a career in the fascinating field of research, with a focus on medical and pharmacological sciences. With the right credentials and passion, one can make priceless contributions to science and society.